Enanta Pharmaceuticals Inc Free Cash Flow Generation Index

Latest as of June 2025: 0.99x

Enanta Pharmaceuticals Inc free cash flow generation index. Enanta Pharmaceuticals Inc (ENTA) has a Free Cash Flow Generation Index of 0.99x as of June 2025. Free cash flow of $17.35 Million represents 1% of operating cash flow ($17.51 Million).

FCF Generation Index

0.99x
Free Cash Flow / Operating CF

Free Cash Flow

$17.35 Million
USD

Operating Cash Flow

$17.51 Million
USD

Capital Expenditures

$155.00K
USD

Free Cash Flow Generation Index of Enanta Pharmaceuticals Inc (2011–2020)

Free cash flow generation index of Enanta Pharmaceuticals Inc from 2011 to 2020. Historical FCF Generation Index trend for Enanta Pharmaceuticals Inc across 10 annual periods. See Enanta Pharmaceuticals Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Enanta Pharmaceuticals Inc Free Cash Flow Generation Index by Year (2011–2020)

Enanta Pharmaceuticals Inc free cash flow generation index by year from 2011 to 2020. Year-by-year Free Cash Flow Generation Index for Enanta Pharmaceuticals Inc. For the full cash flow conversion analysis, see Enanta Pharmaceuticals Inc (ENTA) cash flow conversion.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2020 0.80x $5.64 Million $7.09 Million $1.45 Million ▼ -13.9%
2019 0.92x $66.00 Million $71.42 Million $5.42 Million ▲ +2.9%
2018 0.90x $26.24 Million $29.22 Million $2.98 Million ▼ -5.7%
2017 0.95x $50.15 Million $52.65 Million $2.51 Million ▲ +9.8%
2016 0.87x $31.07 Million $35.81 Million $4.74 Million ▼ -10.5%
2015 0.97x $74.34 Million $76.67 Million $2.34 Million ▲ +2.2%
2014 0.95x $19.15 Million $20.18 Million $1.03 Million ▲ +0.6%
2013 0.94x $10.05 Million $10.65 Million $606.00K ▼ -4.6%
2012 0.99x $22.37 Million $22.62 Million $252.00K ▲ +0.8%
2011 0.98x $23.57 Million $24.02 Million $445.00K —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).